Cargando…
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study
BACKGROUND: In the American Joint Committee on Cancer (AJCC) classification, acral lentiginous melanoma (ALM) histotype ALM is not included as an independent prognostic factor; in small series its negative prognostic impact on disease-free survival (DFS) and overall survival (OS) has been linked to...
Autores principales: | Mandalà, M., Rutkowski, P., Galli, F., Patuzzo, R., De Giorgi, V., Rulli, E., Gianatti, A., Valeri, B., Merelli, B., Szumera-Ciećkiewicz, A., Massi, D., Maurichi, A., Teterycz, P., Santinami, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271470/ https://www.ncbi.nlm.nih.gov/pubmed/35421840 http://dx.doi.org/10.1016/j.esmoop.2022.100469 |
Ejemplares similares
-
Clinicopathological Features and Prognostic Factors of Primary Acral Melanomas in Caucasians
por: Borkowska, Aneta M., et al.
Publicado: (2020) -
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)
por: Mandalà, Mario, et al.
Publicado: (2020) -
Sequential Acral Lentiginous Melanomas of the Foot
por: Uehara, Jiro, et al.
Publicado: (2010) -
Corrigendum to “Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)” [Eur J Canc 137 (2020). Pages 30–39]
por: Mandalà, Mario, et al.
Publicado: (2020) -
Multiple Primary Acral Lentiginous Melanomas (MPALM)
por: González, Miriam, et al.
Publicado: (2017)